vTv Therapeutics Inc. - Class A Common Stock —— 季度现金流量表 (NASDAQ:VTVT) | MetaTrader

展开完整图表完整图表

Financials

概览声明统计

每季度年度

总资产 38.27 M32.03 M26.45 M99.49 M89.9 M98.81 M 负债总额 23.96 M23.13 M24.04 M28.95 M25.46 M8.85 M 权益总额 14.3 M8.9 M2.4 M70.54 M64.44 M89.96 M 负债及股东权益总额 38.27 M32.03 M26.45 M99.49 M89.9 M98.81 M 总债务 0————— 净债务 -36.75 M—————

新闻

vTv Therapeutics (VTVT) is on the Move, Here's Why the Trend Could be Sustainable

Wall Street Analysts See a 39.9% Upside in vTv Therapeutics (VTVT): Can the Stock Really Move This High?

Evercore ISI首次覆盖vTv Therapeutics股票,给予跑赢大盘评级

Evercore ISI initiates vTv Therapeutics stock with outperform rating

BTIG重申买入评级,维持vTv Therapeutics目标价49美元

BTIG reiterates Buy on vTv Therapeutics stock, $49 target maintained

VTv Stock: Cadisegliatin's Phase 3 CATT1 Readout Is The Next Catalyst (NASDAQ:VTVT)

vTv Therapeutics扩大与诺华生物制药的HPP737许可协议

vTv Therapeutics expands HPP737 license agreement with Newsoara Biopharma

vTv将PDE4抑制剂的Newsoara许可协议扩展至全球范围

vTv expands Newsoara license deal for PDE4 inhibitor to global rights

Roth/MKM 对 vTv Therapeutics 股票启动覆盖并给予"买入"评级